Maria José Pérez Sáez
banner
mjoseperezsaez.bsky.social
Maria José Pérez Sáez
@mjoseperezsaez.bsky.social
Nefróloga en el Hospital del Mar, Barcelona
Trasplante Renal
Pinned
Happy to be in a safe place where we can share scientific content and create community. Happy to meet old and new friends.
It is always exciting to start again!
Reposted by Maria José Pérez Sáez
Exercise-Based Prehabilitation for Kidney Transplant Candidates: The FRAILMar Randomized Controlled Trial

bit.ly/P%C3%A9rez-S...

@mjoseperezsaez.bsky.social #VisualAbstract
September 22, 2025 at 10:02 AM
Reposted by Maria José Pérez Sáez
Una candidatura ABIERTA donde todos somos protagonistas. Tu VOZ es nuestra VOZ, Súmate ➕ #TodossomosSEN

sites.google.com/view/todosso...
TodosSomosSEN-Pepa Soler
Una Candidatura RENOVADA, CON LOGROS CONSOLIDADOS, CON PROYECTOS EN MARCHA Y NUEVOS RETOS CON CONTENIDO, CON PALABRAS QUE CUENTAN TODOS SOMOS S.E.N. ¡SÚMATE!
sites.google.com
September 2, 2025 at 6:49 AM
Reposted by Maria José Pérez Sáez
Nos presentamos con mucha ilusión y responsabilidad a la Junta Directiva de la S.E.N. 2026-2029. Una candidatura para TODOS! Conócela y súmate si lo deseas! ⬇️⬇️⬇️
sites.google.com/view/todosso...
September 2, 2025 at 9:29 AM
📢 Prehabilitation in kidney transplant candidates shows promise in improving patient readiness. A step forward in optimizing care before surgery. Tremendous collaborative work at @hospitaldelmar.bsky.social selected by @asnkidney.bsky.social for ASN in the loop this week. 💪🏼
Exercise-Based Prehabilitation for Kidney Transplant Candidates: The FRAILMar Randomized Controlled Trial

bit.ly/P%C3%A9rez-S...

@mjoseperezsaez.bsky.social
August 28, 2025 at 1:40 PM
Reposted by Maria José Pérez Sáez
Aquí os dejamos una pincelada del proyecto COMPARTE-TR
Súmate! @senefrologia.bsky.social @auxiliadoramaz2.bsky.social @pepasolerr.bsky.social
July 18, 2025 at 2:39 PM
Por qué esta candidatura? Porque creemos que el trasplante renal es de TODOS los nefrólogos, por eso 🔜 proyecto COMPARTE-TR. Súmate!
July 12, 2025 at 5:08 PM
Reposted by Maria José Pérez Sáez
𝐓𝐨𝐝𝐨𝐬 𝐬𝐨𝐦𝐨𝐬 𝐒.𝐄.𝐍.

Una candidatura ABIERTA, donde TODOS somos los protagonistas!!

Contamos contigo, súmate a nuestro proyecto.

@SENefrologia @SEDENenfermeria @FundacionRenalE @FNALCER @ERAkidney @ONT_esp @ISNkidneycare @asnpublications @SLANH_ @mjoseperezsaez.bsky.social
July 9, 2025 at 9:51 PM
Reposted by Maria José Pérez Sáez
¿Quieres formar parte de una nueva edición del #CursoTXMir2025 #TrasplanteEnAcción?
🫵🫵¡ABRIMOS INSCRIPCIONES! senefro.org/modules.php?...
Curso dirigido a socios MIR4 que quieran formarse en Trasplante Renal 👏
@alexgutierrezd.bsky.social
@martacrespo.bsky.social
@mjoseperezsaez.bsky.social
June 13, 2025 at 11:29 AM
Reposted by Maria José Pérez Sáez
The fight for equality

www.bmj.com/content/388/...
March 13, 2025 at 3:23 PM
Reposted by Maria José Pérez Sáez
February 3, 2025 at 9:44 AM
Reposted by Maria José Pérez Sáez
Excellent work and an essential guide 👍. With the changes in our population of kidney transplant recipients, the urgent need to improve the evaluation and treatment of frailty is becoming more evident every day. @senefrologia.bsky.social @mjoseperezsaez.bsky.social
journals.lww.com/transplantjo...
Unmet Questions About Frailty in Kidney Transplant... : Transplantation
tion with transplant outcomes. Being prefrail significantly impacts both graft and patient survival, often beginning with just 1 Fried criterion. Rather than viewing frailty as a categorical state, it...
journals.lww.com
January 25, 2025 at 6:50 AM
Reposted by Maria José Pérez Sáez
L’Hospital del Mar va mantenir la seva activitat de #trasplantament durant el 2024

Durant els últims dotze mesos, es van portar a terme 112 trasplantaments renals, una xifra que se situa en nivells similars als dels anys anteriors

#OCATT

www.hospitaldelmar.cat/ca/noticies/...
January 22, 2025 at 9:31 AM
Leuven has done it again ☺️
Automated Urinary Chemokine Assays for Noninvasive Detection of Kidney Transplant Rejection: A Prospective Cohort Study

https://bit.ly/4fhzX0U #OpenAccess
December 29, 2024 at 8:28 AM
Improving referral to the KT waiting list should be a priority in renal care health policies and clinical practices
December 18, 2024 at 5:18 PM
Important data for women who also! need to decide and plan our family choices while trying to build scientific careers
jama.com JAMA @jama.com · Nov 27
Success rates of fertility treatment decline with age, most commonly due to declining ovarian function. Author Albert Hsu of University of Cincinnati, Ohio discusses this and more with JAMA Deputy Editor Kristin Walter.

ja.ma/3Vc532S
November 27, 2024 at 8:29 AM
Christine Durand and Dorry Segev showing similar outcomes with HIV donors in HIV recipients. Expanding donors pool. Hopefully Spain following this lead soon #ONT www.nejm.org/doi/full/10....
Safety of Kidney Transplantation from Donors with HIV | NEJM
Kidney transplantation from donors with human immunodeficiency virus (HIV) to recipients with HIV is an emerging practice. It has been performed since 2016 under the U.S. congressional HIV Organ Po...
www.nejm.org
November 27, 2024 at 6:52 AM
Stepping forward to understand mechanistics behind frailty and sarcopenia in KT candidates

academic.oup.com/ckj/advance-...
academic.oup.com
November 25, 2024 at 1:01 PM
Reposted by Maria José Pérez Sáez
Adding ezetimibe to moderate-intensity statins could be a better approach to reach target LDL-C levels with less new-onset diabetes and intolerance than high high-intensity statin strategy. I think that is true for all statin doses in renal transplant recipients
jamanetwork.com/journals/jam...
LDL Cholesterol–Lowering Strategy in ASCVD
This systematic review and individual patient data meta-analysis investigates the association of an alternative low-density lipoprotein (LDL) strategy with differences in long-term efficacy and safety...
jamanetwork.com
November 24, 2024 at 4:59 PM
Important and useful paper for transplant nephrologists!
November 25, 2024 at 7:01 AM
Salir de trabajar ❤️
November 21, 2024 at 4:39 PM
Reposted by Maria José Pérez Sáez
A whopping (~90%) reduction of progression to Type 2 diabetes with tirzepatide (GLP-1 drug, dual receptor) vs placebo in a randomized trial of >2,500 participants with obesity, absolute reduction of 10/100 treated t.co/71hKD8v7Y2
November 13, 2024 at 10:04 PM
Happy to be in a safe place where we can share scientific content and create community. Happy to meet old and new friends.
It is always exciting to start again!
November 18, 2024 at 8:33 PM
Reposted by Maria José Pérez Sáez
📖 KI #ISNFridaySelection: "Effects of dialysate K concentration of 3.0mEq/l with sodium zirconium cyclosilicate on dialysis-free days vs dialysate K concentration of 2.0mEq/l alone on rates of cardiac arrhythmias in HD pts w/hyperkalemia", presented @ #KidneyWk: www.kidney-internati... #NephSky
November 15, 2024 at 6:00 AM